2026 predictions: historic FDA shift, plausible mechanisms, bespoke tx, RFK Jr., biotechs, state AGs, peptides, embryos The Niche fda warning bpc 157 peptide products New Details 157 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 LeadWest Medical FDA Peptide Reclassification 2026: What It Means for Providers BPC 157 500 mcg Oral Capsules